Only 12% of 5000cr fine is recovered

NPPA

New delhi : Only a little portion of 12% of a large sum of overcharging fine worth 4958 crore is recovered by govt.1467 demand notices have been issued to companies for overcharging since the establishment of NPPA. ” Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said in a written reply to the Lok Sabha. Of the total, about 1,282 cases have been registered under Drug Prices Control Order 1995, while 184 cases under the DPCO 2013. “These demand notices relate to a total amount of Rs 4,958.74 crore. Out of the total amount demanded so far, an amount of Rs 598.81 crore has been deposited by the companies to the government. An amount of Rs 3,460.32 crore is under litigation,” Mandaviya said. He added that action for recovery of the overcharged amount is taken as per the provisions of Drug (Prices Control) Order 1995 and Drug (Prices Control) Order 2013. Set up in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of provisions of the Drugs (Prices Control) Order and monitoring of prices of controlled and decontrolled drugs.

Related Posts

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

Ludhiana police seize 56 kg ganja; courier warehouse under scanner

The recovery has raised serious concerns over alleged lapses in parcel screening and monitoring within the logistics chain. The special cell of Ludhiana police has seized more than two quintals…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg